Journal of Neuroimmunology
Volume 218, Issue 1 , Pages 107-111 , 25 January 2010

Dysregulated Epstein-Barr virus infection in patients with CIDP

  • J.D. Lünemann

      Affiliations

    • Laboratory of Viral Immunobiology, Christopher H. Browne Center for Immunology and Immune Diseases, The Rockefeller University, New York, NY 10065, United States
    • Institute of Experimental Immunology, University Hospital Zürich, 8057 Zürich, Switzerland
    • Corresponding Author InformationCorresponding author. Institute of Experimental Immunology, Clinical Immunology and Immunotherapy, University Hospital Zürich, Winterthurerstrasse 190, CH-8057 Zürich, Switzerland. Tel.: +41 44 635 3710; fax: +41 44 635 6883.
    • These authors contributed equally to this work.
    • ,
  • B. Tackenberg

      Affiliations

    • Department of Neurology, Philipps-University, 35039 Marburg, Germany
    • These authors contributed equally to this work.
    • ,
  • A. Stein

      Affiliations

    • Department of Virology, Charité University Medical Center, Humboldt University, 10117 Berlin, Germany
    • ,
  • K.P. Wandinger

      Affiliations

    • Department of Neurology, Charité University Medical Center, Humboldt University, 10117 Berlin, Germany
    • ,
  • W.H. Oertel

      Affiliations

    • Department of Neurology, Philipps-University, 35039 Marburg, Germany
    • ,
  • H.J. Wagner

      Affiliations

    • Department of Pediatric Hematology/Oncology, Justus-Liebig-University, 35392 Giessen, Germany
    • ,
  • C. Münz

      Affiliations

    • Laboratory of Viral Immunobiology, Christopher H. Browne Center for Immunology and Immune Diseases, The Rockefeller University, New York, NY 10065, United States
    • Institute of Experimental Immunology, University Hospital Zürich, 8057 Zürich, Switzerland
    • ,
  • H. Meisel

      Affiliations

    • Department of Virology, Charité University Medical Center, Humboldt University, 10117 Berlin, Germany
    • ,
  • N. Sommer

      Affiliations

    • Dept. of Neurology, Klinikum Christophsbad, 73008 Göppingen, Germany
    • ,
  • F. Zipp

      Affiliations

    • Cecilie-Vogt-Clinic for Molecular Neurology, Charité University Medicine Berlin, 10117 Berlin, Germany

Received 7 September 2009 ,Revised 4 November 2009 ,Accepted 6 November 2009.

References 

  1. European Federation of Neurological Societies/Peripheral Nerve Society. Guideline on management of chronic inflammatory demyelinating polyradiculoneuropathy. Report of a joint task force of the European Federation of Neurological Societies and the Peripheral Nerve Society. J. Peripher. Nerv. Syst. 2005;10:220–228
  2. Bonetti B, Monaco S, Giannini C, Ferrari S, Zanusso G, Rizzuto N. Human peripheral nerve macrophages in normal and pathological conditions. J. Neurol. Sci. 1993;118:158–168
  3. Bouchard C, Lacroix C, Plante V, Adams D, Chedru F, Guglielmi JM, et al. Clinicopathologic findings and prognosis of chronic inflammatory demyelinating polyneuropathy. Neurology. 1999;52:498–503
  4. Gross AJ, Hochberg D, Rand WM, Thorley-Lawson DA. EBV and systemic lupus erythematosus: a new perspective. J. Immunol. 2005;174:6599–6607
  5. Hughes RA, Allen D, Makowska A, Gregson NA. Pathogenesis of chronic inflammatory demyelinating polyradiculoneuropathy. J. Peripher. Nerv. Syst. 2006;11:30–46
  6. Koller H, Kieseier BC, Jander S, Hartung HP. Chronic inflammatory demyelinating polyneuropathy. N. Engl. J. Med. 2005;352:1343–1356
  7. Lunemann JD, Edwards N, Muraro PA, Hayashi S, Cohen JI, Munz C, et al. Increased frequency and broadened specificity of latent EBV nuclear antigen-1-specific T cells in multiple sclerosis. Brain. 2006;129:1493–1506
  8. Lunemann JD, Frey O, Eidner T, Baier M, Roberts S, Sashihara J, et al. Increased frequency of EBV-specific effector memory CD8+ T cells correlates with higher viral load in rheumatoid arthritis. J. Immunol. 2008;181:991–1000
  9. Matsumuro K, Izumo S, Umehara F, Osame M. Chronic inflammatory demyelinating polyneuropathy: histological and immunopathological studies on biopsied sural nerves. J. Neurol. Sci. 1994;127:170–178
  10. McCombe PA, Pollard JD, McLeod JG. Chronic inflammatory demyelinating polyradiculoneuropathy. A clinical and electrophysiological study of 92 cases. Brain. 1987;110(Pt 6):1617–1630
  11. Meffre E, Wardemann H. B-cell tolerance checkpoints in health and autoimmunity. Curr. Opin. Immunol. 2008;20:632–638
  12. Meyer zu Horste G, Hartung HP, Kieseier BC. From bench to bedside—experimental rationale for immune-specific therapies in the inflamed peripheral nerve. Nat. Clin. Pract. Neurol. 2007;3:198–211
  13. Munz C, Lunemann JD, Getts MT, Miller SD. Antiviral immune responses: triggers of or triggered by autoimmunity?. Nat. Rev., Immunol. 2009;9:246–258
  14. Nimmerjahn F, Ravetch JV. Fcgamma receptors as regulators of immune responses. Nat. Rev., Immunol. 2008;8:34–47
  15. Samuels J, Ng YS, Coupillaud C, Paget D, Meffre E. Impaired early B cell tolerance in patients with rheumatoid arthritis. J. Exp. Med. 2005;201:1659–1667
  16. Saperstein DS, Katz JS, Amato AA, Barohn RJ. Clinical spectrum of chronic acquired demyelinating polyneuropathies. Muscle Nerve. 2001;24:311–324
  17. Sundstrom P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nystrom L, et al. An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study. Neurology. 2004;62:2277–2282
  18. Tackenberg B, Lunemann JD, Steinbrecher A, Rothenfusser-Korber E, Sailer M, Bruck W, et al. Classifications and treatment responses in chronic immune-mediated demyelinating polyneuropathy. Neurology. 2007;68:1622–1629
  19. Yang L, Hakoda M, Iwabuchi K, Takeda T, Koike T, Kamatani N, et al. Rheumatoid factors induce signaling from B cells, leading to Epstein-Barr virus and B-cell activation. J. Virol. 2004;78:9918–9923

PII: S0165-5728(09)00462-7

doi: 10.1016/j.jneuroim.2009.11.003

Journal of Neuroimmunology
Volume 218, Issue 1 , Pages 107-111 , 25 January 2010

Article Tools

* Image Usage & Resolution